William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“Why did mammalian red cells give up their nucleus?
Most cells protect their nucleus.
Mammalian red cells do the opposite.
They eject it.
At first glance, this looks like a loss.
No DNA, no repair, no division. A finite lifespan.
But it is better understood as a trade-off.
Removing the nucleus allows the cell to remove something else too:
its mitochondria.
And with that, a potential conflict of interest.
A red cell that carries oxygen but also consumes it would compete with the tissues it serves.
By giving up mitochondria, the red cell commits fully to delivery.
It does not use the oxygen it transports.
It gives it away.
That same simplification has other consequences:
- more space for hemoglobin
- greater deformability in narrow capillaries
- fewer intracellular obstacles to diffusion
- educed capacity to support viral replication
But the central idea is this:
the red cell becomes a specialist by subtraction.
It gives up autonomy to eliminate internal competition and to optimize a single function.
Not every organism makes this choice.
Other vertebrates retain nucleated red cells.
Their constraints are different.
Mammals chose another path.
One that favors efficiency of delivery over cellular independence.
What looks like loss is the elimination of internal conflict.”
Read more on The Blood Project.
Find more posts featuring William Aird on Hemostasis Today.
-
May 19, 2026, 08:35Gokhan Ozdemir: Managing Acute Flow Diverter Stent Thrombosis in a Critical Vertebrobasilar Circulation
-
May 19, 2026, 08:28Rashad Falah: Evaluating Long Term Outcomes and Transfusion Risks in Obscure Gastrointestinal Bleeding
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis